Association of a glutamate (NMDA) subunit receptor gene (GRIN2B) with obsessive-compulsive disorder: a preliminary study
- 621 Downloads
Recent investigation suggests that a reversible glutamatergically mediated thalamocortical-striatal dysfunction may serve as a reliable pathophysiological and treatment response marker for obsessive-compulsive disorder (OCD). We postulated that N-methyl-d-aspartate (NMDA) receptors were involved in OCD, and specifically that polymorphisms in the 3′ untranslated region of GRIN2B (glutamate receptor, ionotropic, N-methyl-d-aspartate 2B) were associated with OCD in affected families.
The objective of this investigation was to test the association between GRIN2B variants and transmission of the OCD trait using a family-based design.
Using the Family Based Association Test (FBAT), we tested for association with OCD diagnosis in 130 families, and also performed a haplotype analysis. FBAT was additionally used in a subset of 98 families to test for association with the quantitative phenotype of lifetime OCD symptom severity.
Under a non-additive model of inheritance, the 5072T/G variant was significantly associated with OCD even after correcting for the number of models tested (P=0.014). In addition, there was a significant positive association with OCD diagnosis (P=0.002) for the 5072G–5988T haplotype under the recessive model.
Although preliminary and requiring replication in larger samples, these results provide evidence that GRIN2B may be associated with susceptibility to OCD. Coupled with basic neuroscience and clinical neuroimaging findings in patients with OCD, our results provide new and converging support for the role of altered glutamatergic neurotransmission in the pathogenesis of OCD.
KeywordsObsessive-compulsive disorder Glutamate NMDA receptor Genetics
Valuable assistance from Sajid Shaikh, Nicole King, Mary Smirniw, Joanna McBride, Vytas Velyvis, and Eliza Burroughs is appreciated. This study was performed in compliance with the laws of Canada and the province of Ontario.
Financial support was provided by the Ontario Mental Health Foundation through a Research Training Fellowship (P.D.A.) and Type B grant (P.D.A., E.M., J.L.K., M.A.R.), and the Canadian Institutes for Health Research (MOP-38077) (P.D.A., E.M., J.L.K., M.A.R.). Dr. Rosenberg receives support from the State of Michigan Joe F. Young Sr Psychiatric Research and Training Program, the Miriam L. Hamburger Endowed Chair at Children’s Hospital of Michigan and Wayne State University, Detroit, Mich., USA and the National Institute of Mental Health (R01MH59299; RO1MH065122; K24MH02037).
- Alsobrook J, Leckman J, Goodman W, Rasmussen S, Pauls D (1999) Segregation analysis of obsessive-compulsive disorder using symptom-based factor scores. Am J Med Genet (Neuropsychiatr Genet) 88:669–675Google Scholar
- Auer DP, Putz B, Kraft E, Lipinski B, Schill J, Holsboer F (2000) Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study. Biol Psychiatry 47:305–313Google Scholar
- Bronstein Y, Cummings J (2001) Neurochemistry of frontal-subcortical circuits. In: Lichter D, Cummings J (eds) Frontal-subcortical circuits in psychiatric and neurological disorders. Guilford, New York, pp 59–91Google Scholar
- Camarena B, Nicolini H (2002) Family-based association analysis of 5-HT1Db receptor gene in obsessive-compulsive disorder. Int J Neuropsychopharmacol 5:S116Google Scholar
- Carey G, Gottesman I (1981) Twin and family studies of anxiety, phobic and obsessive disorders. In: Klein D, Rabkin J (eds) Anxiety: new research and changing concepts. Raven, New YorkGoogle Scholar
- First M, Spitzer R, Gibbon M, Williams J (1996) Structured clinical interview for DSM-IV-TR axis I disorders, patient edition. (SCID-I/P, version 2.0). Biometrics Research, New York State Psychiatric InstituteGoogle Scholar
- Glatt C, Freimer N (2002) Association analysis of candidate genes for neuropsychiatric disease: the perpetual campaign. Trends Genet 18:307–312Google Scholar
- Hanna G, Veenstra-VanderWeele J, Cox N, Boehnke M, Himle J, Curtis G, Leventhal B, Cook E (2002) Genome-wide linkage analysis of families with obsessive-compulsive disorder ascertained through pediatric probands. Am J Med Genet (Neuropsychiatr Genet) 114:541–552Google Scholar
- Krystal J, Belger A, D’Souza D, Anand A, Charney D, Aghajanian G, Moghaddam B (1999) Therapeutic implications of the hyperglutamatergic effects of NMDA antagonists. Neuropsychopharmacology 21:S143–S157Google Scholar
- Macciardi F (2003) Multiple testing in genetic association studies: to correct or not to correct? Am J Med Genet 122B:31–32Google Scholar
- Nicolini H, Hanna G, Baxter L, Schwartz J, Weissbacker K, Spence M (1991) Segregation analysis of obsessive compulsive and associated disorders. Ursus Medicus 1:25–28Google Scholar
- Nyholt D (2001) Genetic case-control association studies—correcting for multiple testing. Hum Genet 109:564–565Google Scholar
- Pauls D (2001) The genetics of obsessive-compulsive disorder. Fifth International Obsessive Compulsive Disorder Conference, Sardinia, ItalyGoogle Scholar
- Perneger T (1998) What’s wrong with Bonferroni adjustments. BMJ 316:1236–1238Google Scholar
- Rasmussen SA, Eisen JL (1994) The epidemiology and differential diagnosis of obsessive compulsive disorder. J Clin Psychiatry 55:5–10; discussion 11–14Google Scholar
- Rauch S, Whalen P, Dougherty D, Jenike M (1998) Neurobiologic models of obsessive-compulsive disorder. In: Jenike M, Baer L, Minichiello W (eds) Obsessive-compulsive disorders: practical management. Mosby, St Louis, pp 222–253Google Scholar
- Rosenberg D (2002) Selective serotonin-reuptake inhibitors. In: Rosenberg D, Davanzo P, Gershon S (eds) Pharmacotherapy for child and adolescent psychiatric disorders. Dekker, New York, pp 223–296Google Scholar
- Rosenberg D, MacMillan S (2002) Imaging and neurocircuitry of OCD. In: Davis K, Nemeroff C, Coyle J, Charney D (eds) Neuropsychopharmacology: the 5th generation of progress. Lippincott, Williams and Wilkins, Baltimore, pp 1621–1646Google Scholar
- Rosenberg D, MacMaster F, Keshavan M, Fitzgerald K, Stewart C, Moore G (2000) Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine. J Am Acad Child Adolesc Psychiatry 39:1096–1103Google Scholar
- Williams N, Bowen T, Spurlock G, Norton N, Williams H, Hoogendoorn B, Owen M, O’Donovan M (2002) Determination of the genomic structure and mutation screening in schizophrenic individuals for five subunits of the N-methyl-d-aspartate glutamate receptor. Mol Psychiatry 7:508–514CrossRefPubMedGoogle Scholar